F-group (family)
109.3.1.2 Ank,Ank_2
Ligands and drugs
2,546
Member domains
227
with ligand contacts (≤ 4 Å)
8.9% of members
128
with DrugDomain annotations
5.0% of members
64
with a DrugBank compound
2.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 109.3.1.2 belongs to X-group 109 Repetitive alpha hairpins, which binds 9.1 ligand superclasses per 20 proteins, broader than 82% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03775 | DTB | Dethiobiotin | 12 |
| DB03401 | I3P | 1D-myo-inositol 1,4,5-trisphosphate | 4 |
| DB09061 | — | Cannabidiol | 3 |
| DB14011 | — | — | 3 |
| DB00142 | — | Glutamic acid | 2 |
| DB00171 | ATP | ATP | 2 |
| DB00825 | — | — | 2 |
| DB01744 | — | Camphor | 2 |
| DB03103 | TYD | Thymidine-5'- Diphosphate | 2 |
| DB11345 | — | — | 2 |
| DB11755 | — | Tetrahydrocannabivarin | 2 |
| DB14050 | — | — | 2 |
| DB00795 | — | Sulfasalazine | 1 |
| DB01103 | — | — | 1 |
| DB04315 | GDP | Guanosine-5'-Diphosphate | 1 |
| DB05212 | — | — | 1 |
| DB05767 | — | — | 1 |
| DB09086 | — | Eugenol | 1 |
| DB11148 | — | — | 1 |
| DB12010 | — | Fostamatinib | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| XJ7 | (2S)-1-(butanoyloxy)-3-{[(R)-hydroxy{[(1r,2R,3S,4S,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propan-2-yl tridecanoate | 26 |
| FZ4 | 2-aminoethyl diphenylborinate | 20 |
| PIO | [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate | 16 |
| DTB | 6-(5-METHYL-2-OXO-IMIDAZOLIDIN-4-YL)-HEXANOIC ACID | 12 |
| RTO | 4-(dipropylsulfamoyl)benzoic acid | 12 |
| POV | (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate | 10 |
| A0O | 7-methoxy-8-(3-methylbut-2-enyl)chromen-2-one | 8 |
| CL | CHLORIDE ION | 8 |
| ZNmetal | ZINC ION | 8 |
| NAmetal | SODIUM ION | 7 |
| 6OU | [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate | 6 |
| 25A | 5'-O-MONOPHOSPHORYLADENYLYL(2'->5')ADENYLYL(2'->5')ADENOSINE | 5 |
| T3F | (3R,4S,5R,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl][hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate | 5 |
| I3P | D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE | 4 |
| MGmetal | MAGNESIUM ION | 4 |
| O6S | (4-oxo-5-phenyl-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)methyl 3-(3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)propanoate | 4 |
| PCW | 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 4 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 4 |
| YBG | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol | 4 |
| T3Q | [(3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl][hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate | 3 |